MAT2A inhibitor AG-270/S095033 in patients with advanced malignancies: a phase I trial.
Saved in:
| Title: | MAT2A inhibitor AG-270/S095033 in patients with advanced malignancies: a phase I trial. |
|---|---|
| Authors: | Gounder M; Memorial Sloan Kettering Cancer Center; Weill Cornell Medical College, New York, NY, USA., Johnson M; Sarah Cannon Research Institute, Nashville, TN, USA., Heist RS; Massachusetts General Hospital, Boston, MA, USA., Shapiro GI; Dana-Farber Cancer Center, Boston, MA, USA., Postel-Vinay S; Institut Gustave Roussy and U981 INSERM, Villejuif, France.; University College of London, England, UK., Wilson FH; Yale Cancer Center, New Haven, CT, USA., Garralda E; Vall d'Hebron Institute of Oncology, Barcelona, Spain., Wulf G; Beth Israel Deaconess Medical Center, Boston, MA, USA., Almon C; Agios Pharmaceuticals Inc., Cambridge, MA, USA., Nabhan S; Agios Pharmaceuticals Inc., Cambridge, MA, USA., Aguado-Fraile E; Agios Pharmaceuticals Inc., Cambridge, MA, USA., He P; Servier, Boston, USA., Romagnoli M; Servier, Gif-sur-Yvette, France., Hossain M; Agios Pharmaceuticals Inc., Cambridge, MA, USA.; Servier, Boston, USA., Narayanaswamy R; Servier, Boston, USA., Sadou-Dubourgnoux A; Servier, Gif-sur-Yvette, France., Cooper M; Agios Pharmaceuticals Inc., Cambridge, MA, USA.; Servier, Boston, USA., Askoxylakis V; Servier, Boston, USA., Burris HA; Sarah Cannon Research Institute, Nashville, TN, USA., Tabernero J; Vall d'Hebron Institute of Oncology, Barcelona, Spain. jtabernero@vhio.net. |
| Source: | Nature communications [Nat Commun] 2025 Jan 06; Vol. 16 (1), pp. 423. Date of Electronic Publication: 2025 Jan 06. |
| Publication Type: | Journal Article; Clinical Trial, Phase I |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2041-1723 |
|---|---|
| DOI: | 10.1038/s41467-024-55316-5 |
